The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury

Journal of Hepatology

Volumn 66, Issue 3, 2017, Pages 619-630

  Lukacs Kornek, Veronika ^a   Lammert, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Immune crosstalk; Inflammation; Progenitor cells; Regeneration

Indexed keywords

CELL MARKER; BIOLOGICAL MARKER;

CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC LIVER DISEASE; HEPATITIS; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL SELF-RENEWAL; ANIMAL; BIOLOGICAL THERAPY; CELL MOTION; CYTOLOGY; INJURIES; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; STEM CELL NICHE;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; STEM CELL NICHE; STEM CELLS;

EID: 85008419404     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.10.033     Document Type: Review

References (121)

1. [1] Bottcher, J.P., Schanz, O., Wohlleber, D., Abdullah, Z., Debey-Pascher, S., Staratschek-Jox, A., et al. Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity. Cell Rep 3 (2013), 779–795.
2. [2] Crispe, I.N., Immune tolerance in liver disease. Hepatology 60 (2014), 2109–2117.
3. [3] Miyajima, A., Tanaka, M., Itoh, T., Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell 14 (2014), 561–574.
4. [4] Malato, Y., Naqvi, S., Schurmann, N., Ng, R., Wang, B., Zape, J., et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 121 (2011), 4850–4860.
5. [5] Tarlow, B.D., Finegold, M.J., Grompe, M., Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury. Hepatology 60 (2014), 278–289.
6. [6] Yanger, K., Knigin, D., Zong, Y., Maggs, L., Gu, G., Akiyama, H., et al. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15 (2014), 340–349.
7. [7] Wang, B., Zhao, L., Fish, M., Logan, C.Y., Nusse, R., Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524 (2015), 180–185.
8. [8] Dolle, L., Best, J., Mei, J., Al Battah, F., Reynaert, H., van Grunsven, L.A., et al. The quest for liver progenitor cells: a practical point of view. J Hepatol 52 (2010), 117–129.
9. [9] Dorrell, C., Erker, L., Lanxon-Cookson, K.M., Abraham, S.L., Victoroff, T., Ro, S., et al. Surface markers for the murine oval cell response. Hepatology 48 (2008), 1282–1291.
10. [10] Gouw, A.S., Clouston, A.D., Theise, N.D., Ductular reactions in human liver: diversity at the interface. Hepatology 54 (2011), 1853–1863.
11. [11] Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43 (2011), 34–41.
12. [12] Espanol-Suner, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143 (2012), 1564–1575, e1567.
13. [13] Shin, S., Upadhyay, N., Greenbaum, L.E., Kaestner, K.H., Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury. Gastroenterology 148 (2015), 192–202, e193.
14. [14] Jors, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Durl, S., Ferrer, J., et al. Lineage fate of ductular reactions in liver injury and carcinogenesis. J Clin Invest 125 (2015), 2445–2457.
15. [15] Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162 (2015), 766–779.
16. [16] Lu, W.Y., Bird, T.G., Boulter, L., Tsuchiya, A., Cole, A.M., Hay, T., et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol 17 (2015), 971–983.
17. [17] Kohn-Gaone, J., Dwyer, B.J., Grzelak, C.A., Miller, G., Shackel, N.A., Ramm, G.A., et al. Divergent inflammatory, fibrogenic, and liver progenitor cell dynamics in two common mouse models of chronic liver injury. Am J Pathol 186 (2016), 1762–1774.
18. [18] Eckert, C., Kim, Y.O., Julich, H., Heier, E.C., Klein, N., Krause, E., et al. Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver. Am J Physiol Gastrointest Liver Physiol 310 (2016), G1–G12.
19. [19] Isse, K., Lesniak, A., Grama, K., Maier, J., Specht, S., Castillo-Rama, M., et al. Preexisting epithelial diversity in normal human livers: a tissue-tethered cytometric analysis in portal/periportal epithelial cells. Hepatology 57 (2013), 1632–1643.
20. [20] Yanger, K., Zong, Y., Maggs, L.R., Shapira, S.N., Maddipati, R., Aiello, N.M., et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 27 (2013), 719–724.
21. [21] Fan, B., Malato, Y., Calvisi, D.F., Naqvi, S., Razumilava, N., Ribback, S., et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 122 (2012), 2911–2915.
22. [22] Yovchev, M.I., Locker, J., Oertel, M., Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes. J Hepatol 64 (2016), 1348–1357.
23. [23] Yimlamai, D., Christodoulou, C., Galli, G.G., Yanger, K., Pepe-Mooney, B., Gurung, B., et al. Hippo pathway activity influences liver cell fate. Cell 157 (2014), 1324–1338.
24. [24] Duncan, A.W., Taylor, M.H., Hickey, R.D., Hanlon Newell, A.E., Lenzi, M.L., Olson, S.B., et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467 (2010), 707–710.
25. [25] Spee, B., Carpino, G., Schotanus, B.A., Katoonizadeh, A., Vander Borght, S., Gaudio, E., et al. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 59 (2010), 247–257.
26. [26] Dorrell, C., Erker, L., Schug, J., Kopp, J.L., Canaday, P.S., Fox, A.J., et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 25 (2011), 1193–1203.
27. [27] Yovchev, M.I., Grozdanov, P.N., Zhou, H., Racherla, H., Guha, C., Dabeva, M.D., Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 47 (2008), 636–647.
28. [28] Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 (2015), 299–312.
29. [29] Rodrigo-Torres, D., Affo, S., Coll, M., Morales-Ibanez, O., Millan, C., Blaya, D., et al. The biliary epithelium gives rise to liver progenitor cells. Hepatology 60 (2014), 1367–1377.
30. [30] Dolle, L., Best, J., Empsen, C., Mei, J., Van Rossen, E., Roelandt, P., et al. Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naive mice. Hepatology 55 (2012), 540–552.
31. [31] Rountree, C.B., Barsky, L., Ge, S., Zhu, J., Senadheera, S., Crooks, G.M., A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 25 (2007), 2419–2429.
32. [32] Rountree, C.B., Ding, W., Dang, H., Vankirk, C., Crooks, G.M., Isolation of CD133+ liver stem cells for clonal expansion. J Vis Exp 35 (2011), 5110–5121, 10.3791/3183.
33. [33] Malinen, M.M., Kanninen, L.K., Corlu, A., Isoniemi, H.M., Lou, Y.R., Yliperttula, M.L., et al. Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels. Biomaterials 35 (2014), 5110–5121.
34. [34] Suzuki, A., Sekiya, S., Onishi, M., Oshima, N., Kiyonari, H., Nakauchi, H., et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48 (2008), 1964–1978.
35. [35] Petersen, B.E., Grossbard, B., Hatch, H., Pi, L., Deng, J., Scott, E.W., Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 37 (2003), 632–640.
36. [36] Okabe, M., Tsukahara, Y., Tanaka, M., Suzuki, K., Saito, S., Kamiya, Y., et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 136 (2009), 1951–1960.
37. [37] Vander Borght, S., Libbrecht, L., Katoonizadeh, A., van Pelt, J., Cassiman, D., Nevens, F., et al. Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences. J Histochem Cytochem 54 (2006), 1051–1059.
38. [38] Hu, M., Kurobe, M., Jeong, Y.J., Fuerer, C., Ghole, S., Nusse, R., et al. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133 (2007), 1579–1591.
39. [39] Kaneko, K., Kamimoto, K., Miyajima, A., Itoh, T., Adaptive remodeling of the biliary architecture underlies liver homeostasis. Hepatology 61 (2015), 2056–2066.
40. [40] Kordes, C., Sawitza, I., Gotze, S., Herebian, D., Haussinger, D., Hepatic stellate cells contribute to progenitor cells and liver regeneration. J Clin Invest 124 (2014), 5503–5515.
41. [41] Kordes, C., Sawitza, I., Muller-Marbach, A., Ale-Agha, N., Keitel, V., Klonowski-Stumpe, H., et al. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 352 (2007), 410–417.
42. [42] Watt, F.M., Mammalian skin cell biology: at the interface between laboratory and clinic. Science 346 (2014), 937–940.
43. [43] Karin, M., Clevers, H., Reparative inflammation takes charge of tissue regeneration. Nature 529 (2016), 307–315.
44. [44] Van Hul, N.K., Abarca-Quinones, J., Sempoux, C., Horsmans, Y., Leclercq, I.A., Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 49 (2009), 1625–1635.
45. [45] Vestentoft, P.S., Jelnes, P., Andersen, J.B., Tran, T.A., Jorgensen, T., Rasmussen, M., et al. Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair. Fibrogenesis Tissue Repair, 6, 2013, 21.
46. [46] Kourouklis, A.P., Kaylan, K.B., Underhill, G.H., Substrate stiffness and matrix composition coordinately control the differentiation of liver progenitor cells. Biomaterials 99 (2016), 82–94.
47. [47] Lorenzini, S., Bird, T.G., Boulter, L., Bellamy, C., Samuel, K., Aucott, R., et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 59 (2010), 645–654.
48. [48] Kaylan, K.B., Ermilova, V., Yada, R.C., Underhill, G.H., Combinatorial microenvironmental regulation of liver progenitor differentiation by Notch ligands, TGFbeta, and extracellular matrix. Sci Rep, 6, 2016, 23490.
49. [49] Kuramitsu, K., Sverdlov, D.Y., Liu, S.B., Csizmadia, E., Burkly, L., Schuppan, D., et al. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol 183 (2013), 182–194.
50. [50] Peng, Z.W., Ikenaga, N., Liu, S.B., Sverdlov, D.Y., Vaid, K.A., Dixit, R., et al. Integrin alphavbeta6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis. Hepatology 63 (2016), 217–232.
51. [51] Chen, L., Luo, M., Sun, X., Qin, J., Yu, C., Wen, Y., et al. DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches. Cell Death Dis, 7, 2016, e2257.
52. [52] Pritchard, M.T., Nagy, L.E., Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. Am J Pathol 176 (2010), 2743–2752.
53. [53] Richardson, M.M., Jonsson, J.R., Powell, E.E., Brunt, E.M., Neuschwander-Tetri, B.A., Bhathal, P.S., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 133 (2007), 80–90.
54. [54] Dechene, A., Sowa, J.P., Gieseler, R.K., Jochum, C., Bechmann, L.P., El Fouly, A., et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52 (2010), 1008–1016.
55. [55] Coombes, J.D., Swiderska-Syn, M., Dolle, L., Reid, D., Eksteen, B., Claridge, L., et al. Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. Gut 64 (2015), 1120–1131.
56. [56] Pan, R.L., Wang, P., Xiang, L.X., Shao, J.Z., Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation. J Biol Chem 286 (2011), 12340–12348.
57. [57] Zhu, N.L., Asahina, K., Wang, J., Ueno, A., Lazaro, R., Miyaoka, Y., et al. Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration. J Biol Chem 287 (2012), 10355–10367.
58. [58] Gieseck, R.L. 3rd, Ramalingam, T.R., Hart, K.M., Vannella, K.M., Cantu, D.A., Lu, W.Y., et al. Interleukin-13 activates distinct cellular pathways leading to ductular reaction, steatosis, and fibrosis. Immunity 45 (2016), 145–158.
59. [59] Irvine, K.M., Clouston, A.D., Gadd, V.L., Miller, G.C., Wong, W.Y., Melino, M., et al. Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogenesis Tissue Repair, 8, 2015, 19.
60. [60] Gadd, V.L., Skoien, R., Powell, E.E., Fagan, K.J., Winterford, C., Horsfall, L., et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology 59 (2014), 1393–1405.
61. [61] Kreso, A., Dick, J.E., Evolution of the cancer stem cell model. Cell Stem Cell 14 (2014), 275–291.
62. [62] Libbrecht, L., Hepatic progenitor cells in human liver tumor development. World J Gastroenterol 12 (2006), 6261–6265.
63. [63] Sekiya, S., Suzuki, A., Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 122 (2012), 3914–3918.
64. [64] Yamashita, T., Wang, X.W., Cancer stem cells in the development of liver cancer. J Clin Invest 123 (2013), 1911–1918.
65. [65] DePeralta, D.K., Wei, L., Ghoshal, S., Schmidt, B., Lauwers, G.Y., Lanuti, M., et al. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. Cancer 122 (2016), 1216–1227.
66. [66] Guest, R.V., Boulter, L., Kendall, T.J., Minnis-Lyons, S.E., Walker, R., Wigmore, S.J., et al. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. Cancer Res 74 (2014), 1005–1010.
67. [67] Knight, B., Yeoh, G.C., Husk, K.L., Ly, T., Abraham, L.J., Yu, C., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192 (2000), 1809–1818.
68. [68] Yamada, Y., Kirillova, I., Peschon, J.J., Fausto, N., Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 94 (1997), 1441–1446.
69. [69] Jakubowski, A., Ambrose, C., Parr, M., Lincecum, J.M., Wang, M.Z., Zheng, T.S., et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 115 (2005), 2330–2340.
70. [70] Tirnitz-Parker, J.E., Viebahn, C.S., Jakubowski, A., Klopcic, B.R., Olynyk, J.K., Yeoh, G.C., et al. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 52 (2010), 291–302.
71. [71] Brooling, J.T., Campbell, J.S., Mitchell, C., Yeoh, G.C., Fausto, N., Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 41 (2005), 906–915.
72. [72] Knight, B., Matthews, V.B., Akhurst, B., Croager, E.J., Klinken, E., Abraham, L.J., et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol 83 (2005), 364–374.
73. [73] Yeoh, G.C., Ernst, M., Rose-John, S., Akhurst, B., Payne, C., Long, S., et al. Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation. Hepatology 45 (2007), 486–494.
74. [74] Cressman, D.E., Greenbaum, L.E., DeAngelis, R.A., Ciliberto, G., Furth, E.E., Poli, V., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996), 1379–1383.
75. [75] Omori, N., Evarts, R.P., Omori, M., Hu, Z., Marsden, E.R., Thorgeirsson, S.S., Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 75 (1996), 15–24.
76. [76] Fausto, N., Campbell, J.S., Riehle, K.J., Liver regeneration. J Hepatol 57 (2012), 692–694.
77. [77] Russell, W.E., Kaufmann, W.K., Sitaric, S., Luetteke, N.C., Lee, D.C., Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol Carcinog 15 (1996), 183–189.
78. [78] Lowes, K.N., Croager, E.J., Abraham, L.J., Olynyk, J.K., Yeoh, G.C., Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut 52 (2003), 1327–1332.
79. [79] Davies, R.A., Knight, B., Tian, Y.W., Yeoh, G.C., Olynyk, J.K., Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor. Carcinogenesis 27 (2006), 1607–1616.
80. [80] Pusterla, T., Nemeth, J., Stein, I., Wiechert, L., Knigin, D., Marhenke, S., et al. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. Hepatology 58 (2013), 363–373.
81. [81] Takase, H.M., Itoh, T., Ino, S., Wang, T., Koji, T., Akira, S., et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev 27 (2013), 169–181.
82. [82] Kitade, M., Factor, V.M., Andersen, J.B., Tomokuni, A., Kaji, K., Akita, H., et al. Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes Dev 27 (2013), 1706–1717.
83. [83] Ishikawa, T., Factor, V.M., Marquardt, J.U., Raggi, C., Seo, D., Kitade, M., et al. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology 55 (2012), 1215–1226.
84. [84] Bird, T.G., Lu, W.Y., Boulter, L., Gordon-Keylock, S., Ridgway, R.A., Williams, M.J., et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A 110 (2013), 6542–6547.
85. [85] Hsieh, W.C., Mackinnon, A.C., Lu, W.Y., Jung, J., Boulter, L., Henderson, N.C., et al. Galectin-3 regulates hepatic progenitor cell expansion during liver injury. Gut 64 (2015), 312–321.
86. [86] Wang, Z., Yang, X., Chen, L., Zhi, X., Lu, H., Ning, Y., et al. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury. Arch Toxicol, 2016 [Epub ahead of print].
87. [87] Faust, D., Kletting, S., Ueberham, E., Dietrich, C., Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells. Toxicol Lett 223 (2013), 73–80.
88. [88] Thenappan, A., Li, Y., Kitisin, K., Rashid, A., Shetty, K., Johnson, L., et al. Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver. Hepatology 51 (2010), 1373–1382.
89. [89] Lim, R., Knight, B., Patel, K., McHutchison, J.G., Yeoh, G.C., Olynyk, J.K., Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology 43 (2006), 1074–1083.
90. [90] Jung, Y., Oh, S.H., Witek, R.P., Petersen, B.E., Somatostatin stimulates the migration of hepatic oval cells in the injured rat liver. Liver Int 32 (2012), 312–320.
91. [91] Hatch, H.M., Zheng, D., Jorgensen, M.L., Petersen, B.E., SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 4 (2002), 339–351.
92. [92] Michelotti, G.A., Tucker, A., Swiderska-Syn, M., Machado, M.V., Choi, S.S., Kruger, L., et al. Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches. Gut 65 (2016), 683–692.
93. [93] Boulter, L., Govaere, O., Bird, T.G., Radulescu, S., Ramachandran, P., Pellicoro, A., et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18 (2012), 572–579.
94. [94] Kitade, M., Kaji, K., Yoshiji, H., The relationship between hepatic progenitor cell-mediated liver regeneration and non-parenchymal cells. Hepatol Res 46 (2016), 1187–1193, 10.1111/hepr.12682.
95. [95] Lu, J., Zhou, Y., Hu, T., Zhang, H., Shen, M., Cheng, P., et al. Notch signaling coordinates progenitor cell-mediated biliary regeneration following partial hepatectomy. Sci Rep, 6, 2016, 22754.
96. [96] Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R., et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17 (2007), 2054–2060.
97. [97] Swiderska-Syn, M., Xie, G., Michelotti, G.A., Jewell, M.L., Premont, R.T., Syn, W.K., et al. Hedgehog regulates yes-associated protein 1 in regenerating mouse liver. Hepatology 64 (2016), 232–244.
98. [98] Sicklick, J.K., Li, Y.X., Melhem, A., Schmelzer, E., Zdanowicz, M., Huang, J., et al. Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol Gastrointest Liver Physiol 290 (2006), G859–G870.
99. [99] Ochoa, B., Syn, W.K., Delgado, I., Karaca, G.F., Jung, Y., Wang, J., et al. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 51 (2010), 1712–1723.
100. [100] Choi, S.S., Omenetti, A., Witek, R.P., Moylan, C.A., Syn, W.K., Jung, Y., et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 297 (2009), G1093–G1106.
101. [101] Seki, E., HEDGEHOG Signal in hepatocytes mediates macrophage recruitment: A new mechanism and potential therapeutic target for fatty liver disease. Hepatology 63 (2016), 1071–1073.
102. [102] Munz, M., Baeuerle, P.A., Gires, O., The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69 (2009), 5627–5629.
103. [103] Lu, H., Ma, J., Yang, Y., Shi, W., Luo, L., EpCAM is an endoderm-specific Wnt derepressor that licenses hepatic development. Dev Cell 24 (2013), 543–553.
104. [104] Dolle, L., Theise, N.D., Schmelzer, E., Boulter, L., Gires, O., van Grunsven, L.A., EpCAM and the biology of hepatic stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol 308 (2015), G233–G250.
105. [105] Huch, M., Dolle, L., The plastic cellular states of liver cells: Are EpCAM and Lgr5 fit for purpose?. Hepatology 64 (2016), 652–662.
106. [106] Koo, B.K., Clevers, H., Stem cells marked by the R-spondin receptor LGR5. Gastroenterology 147 (2014), 289–302.
107. [107] Chen, Y., Guldiken, N., Spurny, M., Mohammed, H.H., Haybaeck, J., Pollheimer, M.J., et al. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction. J Pathol 237 (2015), 343–354.
108. [108] Eckert, C., Klein, N., Kornek, M., Lukacs-Kornek, V., The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. Front Immunol, 6, 2015, 179.
109. [109] Elsegood, C.L., Chan, C.W., Degli-Esposti, M.A., Wikstrom, M.E., Domenichini, A., Lazarus, K., et al. Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology 62 (2015), 1272–1284, 10.1002/hep.27977.
110. [110] Castellaneta, A., Di Leo, A., Francavilla, R., Margiotta, M., Barone, M., Amoruso, A., et al. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice. Hepatology 43 (2006), 807–816.
111. [111] Strick-Marchand, H., Masse, G.X., Weiss, M.C., Di Santo, J.P., Lymphocytes support oval cell-dependent liver regeneration. J Immunol 181 (2008), 2764–2771.
112. [112] Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R.G., Kobayashi, N., et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19 (2010), 667–679.
113. [113] Lanzoni, G., Cardinale, V., Carpino, G., The hepatic, biliary, and pancreatic network of stem/progenitor cell niches in humans: A new reference frame for disease and regeneration. Hepatology 64 (2016), 277–286.
114. [114] Schmelzer, E., Zhang, L., Bruce, A., Wauthier, E., Ludlow, J., Yao, H.L., et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 204 (2007), 1973–1987.
115. [115] Lanzoni, G., Oikawa, T., Wang, Y., Cui, C.B., Carpino, G., Cardinale, V., et al. Concise review: clinical programs of stem cell therapies for liver and pancreas. Stem Cells 31 (2013), 2047–2060.
116. [116] Poelstra, K., Schuppan, D., Targeted therapy of liver fibrosis/cirrhosis and its complications. J Hepatol 55 (2011), 726–728.
117. [117] Garg, V., Garg, H., Khan, A., Trehanpati, N., Kumar, A., Sharma, B.C., et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142 (2012), 505–512, e501.
118. [118] Han, Y., Yan, L., Han, G., Zhou, X., Hong, L., Yin, Z., et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant vs. granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy 10 (2008), 390–396.
119. [119] Sancho-Bru, P., Altamirano, J., Rodrigo-Torres, D., Coll, M., Millan, C., Jose Lozano, J., et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 55 (2012), 1931–1941.
120. [120] Roskams, T., Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25 (2006), 3818–3822.
121. [121] Lowes, K.N., Brennan, B.A., Yeoh, G.C., Olynyk, J.K., Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 154 (1999), 537–541.